調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Hematology Analyzers & Reagents Market by Products (3-& 5- part hematology Analyzers, Point-of-Care, & Fully Automated), Consumables (Reagents & Stains), End Users (Research Institute, Hospital, & Clinical Testing Labs) - Global Forecasts to 2019

血液分析器及び試薬のグローバル市場動向（～2019）

◆タイトル：Hematology Analyzers & Reagents Market by Products (3-& 5- part hematology Analyzers, Point-of-Care, & Fully Automated), Consumables (Reagents & Stains), End Users (Research Institute, Hospital, & Clinical Testing Labs) - Global Forecasts to 2019
◆商品コード：Markets-MD-2479
◆調査・発行会社：MarketsandMarkets
◆発行日：2014年5月
◆ページ数：266
◆レポート形式：pdf / 英語
◆納品方法：Eメール
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single userUSD4,950 ⇒換算￥539,550見積依頼/購入/質問フォーム
Multi User（～5名）USD6,650 ⇒換算￥724,850見積依頼/購入/質問フォーム
Corporate licence （社内共有可） USD8,150 ⇒換算￥888,350見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

本調査レポートでは、"血液分析器及び試薬のグローバル市場動向（～2019）"について調査・分析し、イントロダクション、エグゼクティブサマリー、プレミアムインサイト、市場概観、市場の成長要因、阻害要因、市場の機会と課題、産業動向、サプライチェーン分析、市場環境分析、市場の動態、製品別分析、種類別分析、需要先別分析、地域別分析、市場規模及び予測、競争状況、市場シェア分析、新製品発売、主要企業（ベンダー）分析等の情報をお届けいたします。

The global hematology market is estimated to grow at a lower CAGR in developed countries; however, it is expected to witness high growth in emerging countries such as China, India, and Brazil in the next five years. The growth of the hematology analyzers and reagents market is driven by factors such as increasing adoption of automated hematology instruments by diagnostics laboratories, growing development of the high throughput hematology analyzers, integration of basic flow-cytometry techniques in modern hematology analyzers, developments in high sensitivity Point-of-Care hematology testing, and the introduction of technologically advanced hematology instruments. However, slow adoption of advanced hematology instruments in the emerging economies, hematology product recalls, and the high cost of hematology analyzers are restraining the growth of this market. Rapid growth of hematology market in emerging countries such as India, China and Brazil; introduction of digital imaging systems in hematology laboratories; and growing use of microfluidics technology in hematology analyzer are creating opportunities for the growth of the hematology analyzers and reagents market in these regions.
In this report, the global hematology market has been segmented on the basis of type of product (hematology instruments and consumables) & services and by end-users (commercial organizations, stand alone hospitals, research institutes, and clinical testing labs). The hematology consumables market accounts for the largest share of the global hematology analyzers and reagents market in 2014. Factors such as new product launches, development of high throughput screening techniques, and increasing adoption of hematology automation platforms in laboratories are stimulating the growth of the hematology reagents market.
Geographically, North America commands the largest share of 44% of the global hematology analyzers and reagents market in 2014, followed by Europe. The hematology analyzers and reagents market in the North America is primarily driven by various factors including technological advancements, rising incidence/prevalence of patients suffering from blood disorders, increasing funding to research institutes, and presence of large number of well established hematology firms. However, increasing government pressure to reduce the healthcare cost, decreasing reimbursement of laboratory tests, and rising price pressure on the market players are restraining the growth of the market in this region. The Asia-Pacific region is poised to grow at the highest CAGR of 9.4% in the next five years, owing to factors such as large patient population, increasing funding/investment toward the development of hematology products, and growing focus of both international and domestic players.
The global hematology analyzers and reagents market is highly competitive with a large number of big and small market players. As of 2013, the global hematology analyzers and reagents market was dominated by Sysmex Corporation (Japan), Beckman Coulter, Inc. (U.S.), and Abbott Laboratories (U.S.), which together accounted for 83% of the market. New product launches and partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most of the market players to achieve growth in the hematology analyzers and reagents market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends and Porter’s five force model), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high growth segments of the hematology analyzers and reagents market, high-growth regions/countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on hematology analyzers and reagents offered by the top 10 players in the hematology analyzers and reagents market. The report analyzes the hematology analyzers and reagents market by type of product and surgery across geographies

• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the hematology analyzers and reagents market

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various hematology analyzers and reagents across geographies

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the hematology analyzers and reagents market

• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the hematology analyzers and reagents market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 REPORT DESCRIPTION 21
1.3 MARKETS COVERED 22
1.4 STAKEHOLDERS 23
1.5 MARKET SCOPE 24
1.6 RESEARCH METHODOLOGY 24
1.6.1 MARKET SIZE ESTIMATION 26
1.6.2 MARKET CRACKDOWN & DATA TRIANGULATION 28
1.6.3 MARKET SHARE ESTIMATION 28
1.6.4 KEY DATA FROM SECONDARY SOURCES 29
1.6.5 KEY DATA FROM PRIMARY SOURCES 29
1.6.6 ASSUMPTIONS 31
2 EXECUTIVE SUMMARY 32
3 PREMIUM INSIGHTS 36
3.1 GLOBAL HEMATOLOGY MARKET, BY PRODUCT 36
3.2 HEMATOLOGY MARKET, BY REGION AND PRODUCTS 37
3.3 HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY REGION AND END USER 38
3.4 HEMATOLOGY ANALYZERS MARKET, BY TYPE OF AUTOMATION AND REGION 39
3.5 FULLY AUTOMATED HEMATOLOGY ANALYZERS MARKET,
BY TYPE OF PRODUCT AND REGION 40
4 MARKET OVERVIEW 41
4.1 INTRODUCTION 42
4.2 MARKET SEGMENTATION 43
4.2.1 HEMATOLOGY INSTRUMENTS MARKET, BY TYPE 43
4.2.2 HEMATOLOGY ANALYZERS MARKET, BY COMPLEXITY 44
4.2.3 HEMATOLOGY ANALYZERS MARKET, BY TYPE OF AUTOMATION 45
4.2.4 HEMATOLOGY ANALYZERS MARKET, BY PRICE RANGE 45
4.2.5 HEMATOLOGY CONSUMABLES MARKET, BY TYPE 46
4.2.6 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER 47
4.2.7 HEMOSTASIS MARKET, BY PRODUCT 47
4.2.8 IMMUNOHEMATOLOGY MARKET, BY PRODUCT 48
4.2.9 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY GEOGRAPHY 49
4.3 MARKET DYNAMICS 49
4.3.1 MARKET DRIVERS 50
4.3.1.1 Development of high throughput hematology analyzers 50
4.3.1.2 Increasing usage of basic flow cytometry techniques in modern hematology Analyzers 51
4.3.1.3 Increasing adoption of automated hematology instruments by diagnostic laboratories 52
4.3.1.4 Technological advancements 52
4.3.1.5 Development of high-sensitivity point-of-care (POC) hematology testing 53
4.3.2 RESTRAINTS 54
4.3.2.1 Slow adoption of advanced hematology instruments in emerging economies 54
4.3.2.2 Hematology product recalls 54
4.3.2.3 High cost of hematology analyzers 54
4.3.3 OPPORTUNITIES 55
4.3.3.1 Introduction of digital imaging systems in hematology laboratories 55
4.3.3.2 Growing use of microfluidics technology in hematology analyzers 56
4.3.3.3 Rapid growth of hematology market in emerging countries such as India, China, and Brazil in the future 56

4.3.4 CHALLENGES 57
4.3.4.1 Sustainability of players in the highly competitive market 57
4.3.4.2 Stringent and time-consuming regulatory policies 58
5 INDUSTRY ANALYSIS 59
5.1 INTRODUCTION 59
5.2 SUPPLY CHAIN ANALYSIS 60
5.2.1 KEY INFLUENCERS 61
5.2.2 PORTER’S FIVE FORCES ANALYSIS 63
5.2.2.1 Threat from new entrants 63
5.2.2.2 Threat from substitutes 64
5.2.2.3 Bargaining power of suppliers 65
5.2.2.4 Bargaining power of buyers 65
5.2.2.5 Intensity of competitive rivalry 66
5.3 INDUSTRY TRENDS 67
5.3.1 PARTNERSHIPS AMONG HEMATOLOGY INSTRUMENTS AND CONSUMABLES MANUFACTURERS 67
5.3.2 ACQUISITION OF SMALL PLAYERS 67
5.3.3 INCREASING FOCUS TOWARDS REAGENT RENTAL BUSINESS 68
6 HEMATOLOGY PRODUCTS AND SERVICES MARKET 70
6.1 INTRODUCTION 71
6.2 HEMATOLOGY PRODUCTS MARKET 74
6.2.1 HEMATOLOGY INSTRUMENTS 74
6.2.1.1 Hematology analyzers 76
6.2.1.2 Hematology analyzers market, by type of automation 78
6.2.1.2.1 Fully automated hematology analyzers 79
6.2.1.2.1.1 5-part and 6-part differential hematology analyzers 81
6.2.1.2.1.2 3-part differential hematology analyzers 83
6.2.1.2.2 Semi-automated hematology analyzers 84

6.2.1.3 Hematology analyzers, by complexity 85
6.2.1.3.1 Highly complex clinical laboratory analyzers 86
6.2.1.3.2 Hematology analyzers for point-of-care testing 87
6.2.1.4 Hematology analyzers, by price range 89
6.2.1.4.1 High-end hematology analyzers 90
6.2.1.4.2 Low-range and mid-range hematology analyzers 92
6.2.1.5 Slide stainers/makers 93
6.2.2 HEMATOLOGY CONSUMABLES 95
6.2.2.1 Hematology reagents 96
6.2.2.2 Hematology stains 98
6.2.2.3 Controls and calibrators 99
6.3 SERVICES 101
6.4 HEMOSTASIS INSTRUMENTS AND REAGENTS MARKET 102
6.4.1 INTRODUCTION 102
6.4.2 HEMOSTASIS INSTRUMENTS 105
6.4.3 HEMOSTASIS REAGENTS 106
6.5 IMMUNOHEMATOLOGY INSTRUMENTS AND REAGENTS MARKET 108
6.5.1 INTRODUCTION 108
6.5.2 IMMUNOHEMATOLOGY INSTRUMENTS 110
6.5.3 IMMUNOHEMATOLOGY REAGENTS 112
7 GLOBAL HEMATOLOGY MARKET, BY END USER 114
7.1 INTRODUCTION 115
7.2 CLINICAL TESTING LABORATORIES 118
7.3 STAND-ALONE HOSPITALS 119
7.4 RESEARCH INSTITUTIONS 121
7.4.1 PUBLIC AND PRIVATE RESEARCH CENTERS 122
7.4.2 ACADEMIC INSTITUTIONS 124
7.5 COMMERCIAL ORGANIZATIONS 125

8 GEOGRAPHIC ANALYSIS 128
8.1 INTRODUCTION 129
8.2 NORTH AMERICA 130
8.3 EUROPE 138
8.4 ASIA-PACIFIC 146
8.5 ROW 154
9 COMPETITIVE LANDSCAPE 161
9.1 OVERVIEW 161
9.2 MARKET SHARE ANALYSIS, HEMATOLOGY PRODUCTS AND SERVICES MARKET 161
9.3 MARKET SHARE ANALYSIS, HEMOSTASIS INSTRUMENTS AND REAGENTS MARKET 164
9.4 MARKET SHARE ANALYSIS, IMMUNOHEMATOLOGY PRODUCTS AND SERVICES MARKET 166
9.5 COMPETITIVE SITUATION AND TRENDS 168
9.5.1 NEW PRODUCT LAUNCHES 170
9.5.2 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES 176
9.5.3 MERGERS & ACQUISITIONS 182
9.5.4 EXPANSIONS 185
9.5.5 OTHER DEVELOPMENTS 189
10 COMPANY PROFILES 192
10.1 SYSMEX CORPORATION 192
10.2 BECKMAN COULTER, INC.
(A SUBSIDIARY OF DANAHER CORPORATION) 204
10.3 ABBOTT LABORATORIES 214
10.4 SIEMENS HEALTHCARE (A DIVISION OF SIEMENS AG) 219
10.5 HORIBA, LTD. 228
10.6 BIO-RAD LABORATORIES, INC. 235
10.7 BOULE DIAGNOSTICS AB 246
10.8 MINDRAY MEDICAL INTERNATIONAL LIMITED 251
10.9 NIHON KOHDEN CORPORATION 257
10.10 ROCHE DIAGNOSTICS
(A DIVISION OF F. HOFFMANN-LA ROCHE LTD) 261

*Details on Financials, Product & Services, Key Strategy, & Developments might not be captured in case of unlisted companies
* SWOT Analysis and MNM View are provided for top-5 companies only

LIST OF TABLES (80

TABLE 1 GLOBAL HEMATOLOGY PRODUCTS MARKET, BY SEGMENT, 2012–2019 ($MILLION) 32
TABLE 2 GLOBAL HEMATOLOGY MARKET, BY PRODUCTS AND SERVICES, 2012–2019 ($MILLION) 72
TABLE 3 HEMATOLOGY PRODUCTS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION) 73
TABLE 4 GLOBAL HEMATOLOGY MARKET, BY PRODUCTS, 2012–2019 ($MILLION) 74
TABLE 5 GLOBAL HEMATOLOGY INSTRUMENTS MARKET, 2012–2019 ($MILLION) 75
TABLE 6 HEMATOLOGY INSTRUMENTS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION) 76
TABLE 7 HEMATOLOGY ANALYZERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION) 77
TABLE 8 GLOBAL HEMATOLOGY ANALYZERS MARKET, BY TYPE OF AUTOMATION, 2012–2019 ($MILLION) 78
TABLE 9 GLOBAL FULLY AUTOMATED HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2012–2019 ($MILLION) 80
TABLE 10 FULLY AUTOMATED HEMATOLOGY ANALYZERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION) 81
TABLE 11 5-PART AND 6-PART HEMATOLOGY ANALYZERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION) 82
TABLE 12 3-PART DIFFERENTIAL HEMATOLOGY ANALYZERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION) 83
TABLE 13 SEMI-AUTOMATED HEMATOLOGY ANALYZERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION) 84
TABLE 14 GLOBAL HEMATOLOGY ANALYZERS MARKET, BY COMPLEXITY, 2012–2019 ($MILLION) 85
TABLE 15 HIGHLY COMPLEX CLINICAL LABORATORY HEMATOLOGY ANALYZERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION) 86
TABLE 16 HEMATOLOGY ANALYZERS FOR POINT-OF-CARE TESTING MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION) 88
TABLE 17 GLOBAL HEMATOLOGY ANALYZERS MARKET, BY PRICE RANGE, 2012–2019 ($MILLION) 89
TABLE 18 HIGH-END HEMATOLOGY ANALYZERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION) 91
TABLE 19 LOW- AND MID-RANGE HEMATOLOGY ANALYZERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION) 92
TABLE 20 HEMATOLOGY SLIDE STAINERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION) 93
TABLE 21 GLOBAL HEMATOLOGY CONSUMABLES MARKET, BY TYPE, 2012–2019 ($MILLION) 96
TABLE 22 GLOBAL HEMATOLOGY REAGENTS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION) 97
TABLE 23 HEMATOLOGY STAINS MARKET, BY GEOGRAPHY, 2012 – 2019 ($MILLION) 98
TABLE 24 GLOBAL HEMATOLOGY CONTROLS AND CALIBRATORS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION) 99
TABLE 25 HEMATOLOGY SERVICE MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION) 101
TABLE 26 GLOBAL HEMOSTASIS MARKET, BY PRODUCTS, 2012–2019 ($MILLION) 103
TABLE 27 HEMOSTASIS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION) 104
TABLE 28 HEMOSTASIS INSTRUMENTS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION) 105
TABLE 29 HEMOSTASIS REAGENTS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION) 107
TABLE 30 GLOBAL IMMUNOHEMATOLOGY MARKET, BY PRODUCTS, 2012–2019 ($MILLION) 109
TABLE 31 GLOBAL IMMUNOHEMATOLOGY MARKET, BY INSTRUMENTS AND REAGENTS, 2012–2019 ($MILLION) 110
TABLE 32 IMMUNOHEMATOLOGY INSTRUMENTS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION) 111
TABLE 33 IMMUNOHEMATOLOGY REAGENTS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION) 112
TABLE 34 GLOBAL HEMATOLOGY MARKET, BY END USERS, 2012–2019 ($MILLION) 116
TABLE 35 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USERS, BY GEOGRAPHY, 2012–2019 ($MILLION) 117
TABLE 36 HEMATOLOGY MARKET FOR CLINICAL TESTING LABORATORIES, BY GEOGRAPHY, 2012–2019 ($MILLION) 118
TABLE 37 HEMATOLOGY MARKET FOR STANDALONE HOSPITALS, BY GEOGRAPHY, 2012–2019 ($MILLION) 120
TABLE 38 GLOBAL HEMATOLOGY MARKET FOR RESEARCH INSTITUTIONS, BY END USER, 2012–2019 ($MILLION) 121
TABLE 39 HEMATOLOGY MARKET FOR RESEARCH INSTITUTIONS, BY GEOGRAPHY, 2012–2019 ($MILLION) 122
TABLE 40 HEMATOLOGY MARKET FOR PUBLIC AND PRIVATE RESEARCH CENTERS, BY GEOGRAPHY, 2012–2019 ($MILLION) 123
TABLE 41 HEMATOLOGY MARKET FOR ACADEMIC INSTITUTIONS, BY GEOGRAPHY, 2012–2019 ($MILLION) 124
TABLE 42 HEMATOLOGY MARKET FOR COMMERCIAL ORGANIZATIONS, BY GEOGRAPHY, 2012–2019 ($MILLION) 126
TABLE 43 HEMATOLOGY PRODUCTS AND SERVICES MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION) 129
TABLE 44 NORTH AMERICA: HEMATOLOGY MARKET, BY PRODUCTS AND SERVICES, 2012–2019 ($MILLION) 131
TABLE 45 NORTH AMERICA: HEMATOLOGY MARKET, BY PRODUCTS, 2012–2019 ($MILLION) 131
TABLE 46 NORTH AMERICA: HEMATOLOGY MARKET, BY INSTRUMENTS, 2012–2019 ($MILLION) 133
TABLE 47 NORTH AMERICA: HEMATOLOGY ANALYZERS MARKET, BY TYPE OF AUTOMATION, 2012–2019 ($MILLION) 134
TABLE 48 NORTH AMERICA: HEMATOLOGY CONSUMABLES MARKET, BY TYPE, 2012–2019 ($MILLION) 135
TABLE 49 NORTH AMERICA: HEMOSTASIS MARKET, BY PRODUCTS, 2012–2019 ($MILLION) 136
TABLE 50 NORTH AMERICA: IMMUNOHEMATOLOGY MARKET, BY INSTRUMENTS AND REAGENTS, 2012–2019 ($MILLION) 136
TABLE 51 NORTH AMERICA: HEMATOLOGY MARKET, BY END USERS, 2012–2019 ($MILLION) 137
TABLE 52 EUROPE: HEMATOLOGY MARKET, BY PRODUCTS AND SERVICES, 2012–2019 ($MILLION) 139
TABLE 53 EUROPE: HEMATOLOGY MARKET, BY PRODUCTS, 2012–2019 ($MILLION) 139
TABLE 54 EUROPE: HEMATOLOGY MARKET, BY INSTRUMENTS, 2012–2019 ($MILLION) 141
TABLE 55 EUROPE: HEMATOLOGY ANALYZERS MARKET, BY TYPE OF AUTOMATION, 2012–2019 ($MILLION) 141
TABLE 56 EUROPE: HEMATOLOGY CONSUMABLES MARKET, BY TYPE, 2012–2019 ($MILLION) 142
TABLE 57 EUROPE: HEMOSTASIS MARKET, BY PRODUCTS, 2012–2019 ($MILLION) 143
TABLE 58 EUROPE: IMMUNOHEMATOLOGY MARKET, BY INSTRUMENTS AND REAGENTS, 2012–2019 ($MILLION) 144
TABLE 59 EUROPE: HEMATOLOGY MARKET, BY END USERS, 2012–2019 ($MILLION) 145
TABLE 60 ASIA-PACIFIC: HEMATOLOGY MARKET, BY PRODUCTS AND SERVICES, 2012–2019 ($MILLION) 147
TABLE 61 ASIA-PACIFIC: HEMATOLOGY PRODUCTS MARKET, 2012–2019 ($MILLION) 148
TABLE 62 ASIA-PACIFIC: HEMATOLOGY MARKET, BY INSTRUMENTS, 2012–2019 ($MILLION) 149
TABLE 63 ASIA-PACIFIC: HEMATOLOGY ANALYZERS MARKET, BY TYPE OF AUTOMATION, 2012–2019 ($MILLION) 150
TABLE 64 ASIA-PACIFIC: HEMATOLOGY CONSUMABLES MARKET, BY TYPE, 2012–2019 ($MILLION) 151
TABLE 65 ASIA-PACIFIC: HEMOSTASIS MARKET, BY PRODUCTS, 2012–2019 ($MILLION) 151
TABLE 66 ASIA-PACIFIC: IMMUNOHEMATOLOGY MARKET, BY PRODUCTS, 2012-2019 ($MILLION) 152
TABLE 67 ASIA-PACIFIC: HEMATOLOGY MARKET, BY END USERS, 2012–2019 ($MILLION) 153
TABLE 68 ROW: HEMATOLOGY MARKET, BY PRODUCTS AND SERVICES, 2012– 2019 ($MILLION) 154
TABLE 69 ROW: HEMATOLOGY PRODUCTS MARKET, BY SEGMENT, 2012–2019 ($MILLION) 155
TABLE 70 ROW: HEMATOLOGY MARKET, BY INSTRUMENTS, 2012–2019 ($MILLION) 155
TABLE 71 ROW: HEMATOLOGY ANALYZERS MARKET, BY TYPE OF AUTOMATION, 2012–2019 ($MILLION) 156
TABLE 72 ROW: HEMATOLOGY CONSUMABLES MARKET, BY TYPE, 2012–2019 ($MILLION) 157
TABLE 73 ROW: HEMOSTASIS MARKET, BY PRODUCTS, 2012–2019 ($MILLION) 158
TABLE 74 ROW: IMMUNOHEMATOLOGY MARKET, BY PRODUCTS, 2012–2019 ($MILLION) 159
TABLE 75 ROW: HEMATOLOGY MARKET, BY END USERS, 2012–2019 ($MILLION) 160
TABLE 76 NEW PRODUCT LAUNCHES, 2011–2014 170
TABLE 77 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES, 2011–2014 177
TABLE 78 MERGERS & ACQUISITIONS, 2011–2014 182
TABLE 79 EXPANSIONS, 2011–2014 185
TABLE 80 OTHER DEVELOPMENTS, 2011–2014 189

LIST OF FIGURES (33)

FIGURE 1 GLOBAL HEMATOLOGY ANALYZERS AND REAGENTS MARKET: RESEARCH METHODOLOGY 25
FIGURE 2 MARKET SIZE ESTIMATION METHODOLOGY 27
FIGURE 3 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY GEOGRAPHY, 2014 34
FIGURE 4 GLOBAL HEMATOLOGY MARKET, BY PRODUCT, 2014 36
FIGURE 5 HEMATOLOGY MARKET, BY REGION AND PRODUCT, 2014 VS. 2019 37
FIGURE 6 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY REGION AND END USER, 2014 VS. 2019 38
FIGURE 7 HEMATOLOGY ANALYZERS MARKET, BY TYPE OF AUTOMATION AND REGION, 2014 VS. 2019 39
FIGURE 8 FULLY AUTOMATED HEMATOLOGY ANALYZERS MARKET, BY TYPE OF PRODUCT AND REGION, 2014 VS. 2019 40
FIGURE 9 HEMATOLOGY ANALYZERS AND REAGENTS MARKET SEGMENTATION 43
FIGURE 10 HEMATOLOGY INSTRUMENTS MARKET SEGMENTATION, BY TYPE 44
FIGURE 11 HEMATOLOGY ANALYZERS MARKET SEGMENTATION, BY COMPLEXITY 44
FIGURE 12 HEMATOLOGY ANALYZERS MARKET SEGMENTATION, BY TYPE OF AUTOMATION 45
FIGURE 13 HEMATOLOGY ANALYZERS MARKET SEGMENTATION, BY PRICE RANGE 46
FIGURE 14 HEMATOLOGY CONSUMABLES MARKET SEGMENTATION, BY TYPE 46
FIGURE 15 HEMATOLOGY ANALYZERS AND REAGENTS MARKET SEGMENTATION, BY END USER 47
FIGURE 16 HEMOSTASIS MARKET SEGMENTATION, BY PRODUCT 48
FIGURE 17 IMMUNOHEMATOLOGY MARKET SEGMENTATION, BY PRODUCT 48
FIGURE 18 HEMATOLOGY ANALYZERS AND REAGENTS MARKET SEGMENTATION, BY GEOGRAPHY 49
FIGURE 19 MARKET DYNAMICS: GLOBAL HEMATOLOGY ANALYZERS AND REAGENTS MARKET 50
FIGURE 20 SUPPLY CHAIN: HEMATOLOGY ANALYZERS AND REAGENTS MARKET 60
FIGURE 21 PORTER’S FIVE FORCES ANALYSIS: GLOBAL HEMATOLOGY ANALYZERS AND REAGENTS MARKET, 2014 63
FIGURE 22 GLOBAL HEMATOLOGY MARKET, BY PRODUCTS AND SERVICES, 2014 VS. 2019 71
FIGURE 23 HEMATOLOGY PRODUCT MARKET, 2014 VS. 2019 72
FIGURE 24 GLOBAL HEMATOLOGY INSTRUMENT MARKET, 2014 VS. 2019 75
FIGURE 25 GLOBAL FULLY AUTOMATED ANALYZERS MARKET, BY TYPE, 2014 VS. 2019 79
FIGURE 26 GLOBAL HEMATOLOGY CONSUMABLES MARKET, 2014 VS. 2019 95
FIGURE 27 GLOBAL HEMOSTASIS MARKET, BY INSTRUMENTS AND REAGENTS, 2014 VS. 2019 102
FIGURE 28 GLOBAL IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2014 VS. 2019 108
FIGURE 29 GLOBAL HEMATOLOGY MARKET, BY END USER, 2014 VS. 2019 115
FIGURE 30 HEMATOLOGY PRODUCTS AND SERVICES MARKET SHARE,BY KEY PLAYERS, 2013 162
FIGURE 31 HEMOSTASIS INSTRUMENTS AND REAGENTS MARKET SHARE,BY KEY PLAYERS, 2013 164
FIGURE 32 IMMUNOHEMATOLOGY PRODUCTS AND SERVICES MARKET SHARE, BY KEY PLAYERS, 2013 166
FIGURE 33 KEY GROWTH STRATEGIES, 2011–2014 169







【レポートのキーワード】

血液分析計、血液分析器、血液分析装置、アナライザ

★調査レポート[血液分析器及び試薬のグローバル市場動向（～2019）] ( Hematology Analyzers & Reagents Market by Products (3-& 5- part hematology Analyzers, Point-of-Care, & Fully Automated), Consumables (Reagents & Stains), End Users (Research Institute, Hospital, & Clinical Testing Labs) - Global Forecasts to 2019 / Markets-MD-2479) 販売に関する免責事項
[血液分析器及び試薬のグローバル市場動向（～2019）] ( Hematology Analyzers & Reagents Market by Products (3-& 5- part hematology Analyzers, Point-of-Care, & Fully Automated), Consumables (Reagents & Stains), End Users (Research Institute, Hospital, & Clinical Testing Labs) - Global Forecasts to 2019 / Markets-MD-2479) についてEメールでお問い合わせ
◆関連調査資料◆
  • 血液分析装置・試薬の世界市場予測（～2023年）
    MD-2479 / MarketsandMarkets / 2018年6月12日 / MarketsandMarketsが発行した当調査レポートでは、血液分析装置・試薬の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品・サービス別分析、価格別分析、需要先別分析、地域別分析、血液分析装置・試薬の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The hematology products market projected to grow at a CAGR of 8.5%.”The global hematology products market is projected to reach USD 4.98 billion by 2023 from USD 3.31 billion in 2018, at a CAGR of 8.5%. Technological advancements in hematology analyzers and reagents, integration of flow cytometry techniques with hematology analyzers, and the increasing incidence of blood disorders are the factors expected to drive the market during the study period. However, the high cost of hematology analyzers, product recalls, and slow adoption of advanced hematology instruments in emerging countries are factors restraining the growth of this market to a certain...
  • フローサイトメトリーの世界市場予測（～2022年）：技術、製品・サービス、用途、エンドユーザー
    MAM-BT-6015 / MarketsandMarkets / 2018年2月20日 / MarketsandMarketsが発行した当調査レポートでは、フローサイトメトリーの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、技術別分析、製品・サービス別分析、需要先別分析、地域別分析、フローサイトメトリーの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The global flow cytometry market is projected to grow at a CAGR of 7.8%.”The global flow cytometry market is projected to reach USD 4.79 billion by 2022 from USD 3.29 billion in 2017, growing at a CAGR of 7.8% from 2017 to 2022. The key factors driving the growth of this market include the continuous technological advancements in the field of flow cytometry, increasing incidence and prevalence of target diseases (such as HIV/AIDS and cancer), and growing adoption of flow cytometry in advanced research activities and clinical trials. However, factors such as the high cost of flow cytometry instruments and...
  • 細胞計測の世界市場予測（～2023年）：計測器、消耗品
    BT-3379 / MarketsandMarkets / 2018年7月19日 / MarketsandMarketsが発行した当調査レポートでは、細胞計測の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、バリューチェーン分析、市場シェア分析、製品別（計測器、消耗品）分析、エンドユーザー別（製薬会社、病院、研究）分析、細胞計測の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global cell counting market is projected to reach USD 12.32 billion by 2023 from USD 8.84 billion in 2018, at a CAGR of 6.8%. Factors contributing to the growth of this market include growing incidence of diseases and disorders, development of enhanced solutions and improved image analysis, and growing use of high-throughput flow cytometry and automated hematology analyzers. The report analyzes the global cell counting market by product, application, end user, and region. On the basis of product, the consumables segment is expected to account for the largest share of the market in 2018. The large share can be...
  • 動物診断の世界市場予測（～2023年）：動物診断機器、動物診断消耗品
    MD2411 / MarketsandMarkets / 2018年7月24日 / MarketsandMarketsが発行した当調査レポートでは、動物診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品別（機器、消耗品）分析、技術別（臨床生化学、尿検査、免疫診断、血液学、分子診断）分析、動物の種類別（犬、猫、馬、牛、豚、家禽）分析、エンドユーザー別分析、動物診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The veterinary diagnostics market is projected to reach USD 4.00 billion by 2023 from USD 2.63 billion in 2018, at a CAGR of 8.8%. Factors such as growing companion animal population, growing prevalence of animal zoonotic diseases, rising demand for animal-derived food products, rising demand for pet insurance & growing animal health expenditure, and the increasing number of veterinary practitioners and income levels in developed economies are expected to drive the growth of the veterinary diagnostics market. However, the increasing pet care costs may restrain the growth of the market. The market is segmented based on the product, technology, animal...
  • In Vitro診断（IVD）の世界市場予測（～2023年）：IVD装置、IVD試薬
    MAM-MD-3609 / MarketsandMarkets / 2018年3月27日 / MarketsandMarketsが発行した当調査レポートでは、In Vitro診断（IVD）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品別分析、技術別分析、用途別分析、地域別分析、In Vitro診断（IVD）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The in vitro diagnostics market is projected to grow at a CAGR of 5.2%.”The in vitro diagnostics market is projected to reach USD 87.93 billion by 2023 from USD 68.12 billion in 2018, at a CAGR of 5.2%. Growth in this market is primarily driven by the increasing burden of chronic diseases (majorly due to the rising geriatric population), rising prevalence of infectious diseases, rising demand for early disease diagnosis using specialized tests, growing awareness of personalized medicine, and increasing adoption of fully-automated instruments and automation in laboratories. Moreover, the development of condition-specific markers and tests, growing significance of companion...
  • イムノアッセイ（免疫学的検定）の世界市場予測（～2023年）：試薬・キット、分析装置、ソフトウェア
    MD4751 / MarketsandMarkets / 2018年5月14日 / MarketsandMarketsが発行した当調査レポートでは、イムノアッセイ（免疫学的検定）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品・サービス（試薬・キット、分析装置、ソフトウェア）別分析、技術別分析、プラットフォーム別分析、用途別分析、イムノアッセイ（免疫学的検定）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global immunoassays market is expected to reach USD 27.15 Billion by 2023 from USD 20.19 Billion in 2018, at a CAGR of 6.1%. The market growth is primarily driven by the increasing incidence of chronic and infectious diseases and technological innovations in immunoassays instruments. The global immunoassays market is segmented by product and service, platform, technology, specimen type, application, end user, and region. By product and service, the market is segmented into reagents and kits, analyzers, and software & services. The immunoassay reagents and kits segment accounted for the largest share of this market in 2017. The large share...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆